TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Paradigm Therapeutics
Curated by ChEMBL
Paradigm Therapeutics
Curated by ChEMBL
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of dopamine reuptake at human recombinant dopamine transporterMore data for this Ligand-Target Pair